Clinical Trials Directory

Trials / Completed

CompletedNCT04538391

Intra Incisional Infiltration of Bupivacaine Versus Meloxicam on Post Cesarean Section Pain Relief

Bupivacaine Versus Meloxicam Infiltration on Post Cesarean Section Pain Relief

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
105 (actual)
Sponsor
Menoufia University · Academic / Other
Sex
Female
Age
21 Years – 40 Years
Healthy volunteers
Accepted

Summary

Investigation: compare the effect of local infiltration of incision site with bupivacaine and local infiltration with meloxicam in women undergoing cesarean sections on postoperative pain relief and analgesic requirement. Condition: post cesarean sections analgesia intervention: infiltration of incision bupivacaine versus meloxicam Phase: Not applicable

Detailed description

study type: randomized clinical trial actual enrollment: 119 allocation: Random intervention model: three groups assignment masking: open lebal primary purpose: pain relief after Cesarean section actual study start: March 3, 2019 Primary Completion: March 5, 2020 actual study completion date: May 9, 2020

Conditions

Interventions

TypeNameDescription
DRUGlocal ifiltration Bupivacaine, Meloxican and placebono other intervention done

Timeline

Start date
2019-03-03
Primary completion
2020-03-05
Completion
2020-05-09
First posted
2020-09-04
Last updated
2020-09-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04538391. Inclusion in this directory is not an endorsement.